Healthcare resources worldwide are coming under tremendous strain from the COVID-19 pandemic, but for healthcare-oriented investors, there’s good reason to believe the sector will remain resilient and reward those who are patient and smart. Private equity activity in healthcare had concluded a banner year in 2019 when the coronavirus hit. Total disclosed deal value hit a record high of $78.9 billion, and the average deal size rose by about 25% as funds completed relatively larger transactions, according to the Bain & Company 2020 M&A report. Excitement about the healthcare sector in North America has been driven by the long-term demographic trend of aging populations, increases in chronic conditions and the ample spending ability of the baby boomer generation now reaching their senior years. The current public health crisis does little to dampen the tailwinds that were giving lift to the healthcare industry. Indeed, the healthcare sector demonstrated during the last recession that investors who remain focused on the fundamental drivers of healthcare expansion will be rewarded.
Read the full article: Industry Voices – Healthcare Deal-Making Should Remain Resilient despite the Coronavirus Pandemic //
Source: https://www.fiercehealthcare.com/hospitals-health-systems/industry-voices-healthcare-deal-making-should-remain-resilient-despite